MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr | ₹1,072 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹2,152 Cr |
Mar2023 | ₹1,813 Cr |
Mar2022 | ₹920 Cr |
Mar2021 | ₹1,137 Cr |
Mar2020 | ₹1,072 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹2,152 Cr | 18.70 | |
Mar2023 | ₹1,813 Cr | 97.15 | |
Mar2022 | ₹920 Cr | -19.12 | |
Mar2021 | ₹1,137 Cr | 6.07 | |
Mar2020 | ₹1,072 Cr | - |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹99,979.2 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 2.1% |
3.7% |
9.5% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses